Short answer
Tempus AI Inc (TEM) filed an 8-K current report with the SEC on October 23, 2026 reporting Item 8.01 (Other Events). $192.5M aggregate cash payments over approximately five years, creating significant contracted data and services revenue.
Tempus AI Inc 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- $192.5M aggregate cash payments over approximately five years, creating significant contracted data and services revenue
- BMS oncology agreement: $137.5M through December 31, 2031, with quarterly invoicing and substantial termination fee
- Pathos neurology agreement: up to $55M for 500,000 records, priced at $100 per delivered record plus $5M for updates
- BMS access to Tempus neurology data and Tempus Agent through Pathos, expanding exposure to therapeutic development
- Neurology data exclusivity limits third-party licensing for up to 18 months, while related-party terms received special committee approval
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Tempus AI Inc 8-K filings
Get the next TEM 8-K as it lands
Follow TEM for push alerts, or ask the research agent what this filing means.